• 検索結果がありません。

Bone Tissue Formation Potential of Porous Carbonate Apatite and Mesenchymal Stem Cell Growth Factor Complex

N/A
N/A
Protected

Academic year: 2021

シェア "Bone Tissue Formation Potential of Porous Carbonate Apatite and Mesenchymal Stem Cell Growth Factor Complex"

Copied!
9
0
0

読み込み中.... (全文を見る)

全文

(1)

LXSMU&–è&½ÏgžãÆ>‘|½Ù

)$

u ¡ n  

%#p$ )$'"!"

#!"'Ø#€

! "

@94E(/,)->6?'CF8D

"<A3:&+*10!2.%#$7=;5<B

› h û Š") b Ò Ì ") y › { f") ê † ‡ ¶") Ó e é#) ­ É ¯ ±")

Bone Tissue Formation Potential of Porous Carbonate Apatite and Mesenchymal Stem Cell Growth Factor Complex

YAMAOKATAKAHIRO"), YASUDATADASHI"), KANAYAMAKEIICHI"), KITAGOMITSUNOBU"), DOIYUTAKA#)and SHIBUTANITOSHIAKI")

°ý#¡ªÃµ”¾?¡ªà£ü=,/H•«íß>"7:38¦G³0FIò$<£üç.ŒJI8+

H"õ”¾=?–è!½Ïgž!RP[Y%^V>ÃBJ4.®õ:2I8+H"…—!–è=?‘»

ñ÷>sô}–è(MSC).Ô2I8,G!½Ïgž:38?FGF-#!BMP-#!PDGF<;.Ô2 I!RP[Y%^V:38?¥=WMV_PQLXSMU!β-]aœšO^QNZ.øó2I8+H"xØ!

õ¹þ¼DõÕv©¼=ïI5ʜtðLXSMU(CAP)ʼnÆ.Íí2I8+H"

ë‚w9?RP[Y%^V:38CAPʼnÆKó+8!CAP-MSC-l§½ÏgžãÆK\TUÞi=

ì×3!õ·¾,E@‘|½ÙKÔ35""¬sÛö35CAP-MSC=½Ïgž:38FGF-#*H+

?!BMP-#KÑj38"¢st¸3ãÆK˜¿35"ãÆK\TUÚâÞi=ì×3!%¬†:(¬

†=õnÐ=r™35"

%¬í9?BMPz9oÜ<~Ãµ>Äj.„FI5"·¾Ãµ|½ú?%¬í9?Dzz:Ým38 MSCz!BMPz,E@FGFz?ŽËK¤35"A5(¬í9?BMPz>·¾‘|½ú.•CŽ-65"

CAPKRP[Y%^V:35MSC,E@½Ïgž>Ñj?õ·¾=ðó9*H1:.¤’2I5"

P%`%V#ʜtðLXSMU!‘»ñ÷>sô}–è!Âck–èÄ´gž!‘|½gž

,=5 >6 B85 <19= 7>1;A >6 ?5@9>4>=B1; B@51B<5=B 9A B85 @575=5@1B9>= >6 ?5@9>4>=B1; B9AAC5" /85 @575=5@1B9>=

9A 3><?>A54 >6 35;;A! 7@>EB8 613B>@A! 1=4 A3166>;4A" %1@2>=1B5 1?1B9B5 81A 255= @5?>@B54 B> 25 1 31=4941B5 A316#

6>;4 <1B5@91; 6>@ 2>=5 @575=5@1B9>=" /85 ?C@?>A5 >6 B89A ABC4G E1A B> 5D1;C1B5 1 3><?;5F >6 31@2>=1B5 1?1B9B5 1=4 <5A5=38G<1; AB5< 35;;A! E9B8 7@>EB8 613B>@ 6>@ 85B5@>B>?93 2>=5 6>@<1B9>=" /85 3><?;5F E1A 7@16B54 C=#

45@ B85 213: A:9= >6 <1BC@54 <1;5 @1BA" /85 7@16B54 <1B5@91;A 1=4 AC@@>C=49=7 A>6B B9AAC5 E5@5 @5<>D54 16B5@

%1=4(E55:A 6>@ 89AB>;>7931; ABC4G" /85 3><?;5F >6 31@2>=1B5 1?1B9B5 1=4 <5A5=38G<1; AB5< 35;;A E9B8 2>=5

<>@?8>;>793 ?@>B59= A8>E54 B85 89785AB 2>=5 6>@<1B9>=" /85 31@2>=1B5 1?1B9B5 E1A @5A>@254 2G >AB5>3;1ABA 1=4 @5?;1354 2G =5E;G 6>@<54 2>=5 B9AAC5"

$ 3><?;5F >6 31@2>=1B5 1?1B9B5 1=4 <5A5=38G<1; AB5< 35;;A E9B8 2>=5 <>@?8>;>793 ?@>B59= 31= 25 1 3>=#

A945@54 1 31=4941B5 6>@ ?5@9>4>=B1; 2>=5 @575=5@1B9>="

Key words: Carbonate apatite, mesenchymal stem cell, fibroblast growth factor, bone morphogenic protein, bone formation

")ÎÖÈn¡n∋qÁdün“ ¡ªànäî

#)ÎÖÈn¡nâ

&!"&!#)' uáƒºæŸæÀ"(&"

")&5?1@B<5=B >6 -5@9>4>=B>;>7G! &9D9A9>= >6 ,@1; )=653B9>=A 1=4 (51;B8

.395=35A

$A189 0=9D5@A9BG .38>>; >6 &5=B9AB@G

#)$A189 0=9D5@A9BG .38>>; >6 &5=B9AB@G (>HC<9"(&"! +9HC8>! '96C&!"&!#)'! *1?1=

(å½#(Ø"€"(Ö¨ù)

(2)

*%

( Ñ

óþN6áDKóþ™öÊI27Wâÿ²˜J"C F;DúV08UX»$Höʦ4ÛYXD/W"N 6áDI2/DU1)kd„€%ˆt*!ã¨!Bg

—íJé¿MJNPÝY>4"¿FHW"*"ÐäÞ?

·ÂJ±¾Çã¨)MSC*Zë½;@áDʦ4:

3[IËy:XD/W#*"”SÊÇJ¯  ã¨E.

WMSCK!SÊîôN6F;DJÞ?ksŠ%ã

¨J×BB I  ;D/6A7EH6!:UIñ©

ã¨!Þã¨!‚Þã¨!Àã¨HGJbÓ¾ÇJ»$

HN6I  =WˆÌZRB@ã¨E.W$*":UI MSCJz5F;D!ß݇‹y¸S‰ep‹ZìÉ

=W9FITV!T‡‹y¸JR54Á@:XW 9F4_UXD/W"9JT0IMSCK°šÁ@æ

½Z¶;D2V!áD“ÊJ°p3Ud²:X!Î*

m̹4« ;D5D/W%&'*"

óþN6áDI27WBg—íF;DKÞÅB—í )Bone Morphogenetic Protein#BMP*(&"$*!J’£ã

¨ R 5 — í)Fibroblast Growth Factor-##

FGF*"%&"(*!Ê)  ·  R 5— í)Platelet-Derived

Growth Factor#PDGF*")*HG4Ëy:XD/W"

ã¨ZáD“ÊIë½=W1Ý!öÊõJOæA2 TLÅ\šº3U!ã¨Zkd„€%ˆtIša:>

DŒÀZÛ/!DYM¬„=W9F4•‘mE.

W"**"ŽKTVkd„€%ˆtF;Dw_tŠdi]

y o _ s)HAP*#!&##*!β-‡ ‹ ê é c ˆ i ` ‚)β- TCP*#$!#%*4ý:XD5@"HAPKN69ÑA4Ë 6!Þq}ˆIµXD/WRJJN6EJ·ý4N F[GH/"O@β-TCPKN6·ýA4ËÕE.

W4!N69ÑAIÐW9F4_UXD/W#$!#%*"HAP ZŒÀã¨Jkd„€%ˆtF;Dë½;@1Ý!¬

„ÓRHAP4gµ±Wä;­IHGJϗFHW9 F4³Ò:XW"•¥!β-TCPJ¼êAK㨌À Jkd„€%ˆtF;DKn:H/FÙ1UXW"?

J@QÁ†!?XUZ¤0åÉF;D^ê²¶]yo _s)CAP*J¶½A4d²:XD/W#&&#(*"CAPK N69ÑA2TLN6·ýAIµXW@QÞáDJk d„€%ˆtF;Dµ[:XW"

?9EªÌ¹J²mKCAPXÖY0IMSCZ‰

ü;!¨üBg—íEìÉZº1@žÝYZ†qs“

ŸI¬„;!N6áD2TLÞÅBˆIC/DËy;

@"

åÉ2TL¥¦

""žÝYJæE

æE¥¦Kv”U#)*J¥¦I%<DæE;@"CAP

¡®FÔÈxZ"#"EßÝ;!›c3IÂÄBÅZ ÛB@":UI#!!MPaF=&ÄZï;!~UX@

CAPZ"õ±4Ç=I8i;DxZ¼#;@"•’

¬PÓ!,žVu&,' E(!!,OE,ž;•õ±£

ô;D¶ÖÅ&!-Z¶=WCAPXÖYZæE;@

)hÆ'mm!Ü:#mm*"

Þ?·ÂJMSCIK†qsÞ?·Â±¾Çã¨

)KE-%!!!DS|\%x_bƒr^cˆ!<r*Z

½/@"&!m!|†kgIØN6¸}Œ`)rdh

ƒon‹²¶"!mMβ-f‡lЇ‹ê!&!Œg/m!]k g ˆ { ‹ ê!"!-FCSo¡D-MEM)Life Technolo- gies!Carlsbad!CA!USA*ZfC;@"CO#_‹d… }%o%)$(,!&-CO#‡u*ID"($!±Œ

ÀZÛ/!ŒÀ™JÔ®K$ƒ­IÛB@"

CAPXÖYIØN6¸}Œ`)#m!/well*Zo¡

;@"Œ`o¡Ó!CAPXÖY0IMSCZ"+"!%cell /well‰ü;!"!±ŒÀ;@)MSCÃ*"ŒÀÓCAP XÖYZ¯/%-y†€ˆ‚]ˆrzt™IDÒk

;!QàÄsí͖½)SEM, S%&!!ƒÆEæ'!w º*ID°çZ;@"

MSCŒÀÓ!CAP-MSCIBg—íF;DBMP-# )BMPÃ*!FGF-#)FGFÃ*Z ‡ u"!!ng/m!I

;DCAPXÖY0Io¡!"õ±ŒÀ2TL:

>DžÝYZæE;@"

#"{Ÿ÷Î

÷Î{ŸIKWistarǹA†qs"!!Ï)¢¿Y

"#)!g*Z%)—)¨Ã%—*ë½;@"DÄ7œ=

ID"!‹´ù;@~‹sxˆ{o%ˆus‡`‚)m

‚v~‹pˆ+!»ÆE´!wº*ÚdøITW L:«>ZÛB@"û$³Zaov%ˆID-€Ó!

j±ZÛ/¬„J%•ZÛB@"§¢½ƒkIDŠœ

“ŸIG¦Z¡1CAPžÝYZ¬„;!m|su_

Š‹ð)m|s‰qp!j%i%!wº*ID“›J

§ÝZÛB@"O@Z.ÃF;Dã¨2TLBg—í Z‰ü;H/CAPXÖYZ|»I¬„;@);"*"

¬„Ó"!±EŽðZÛB@"

H2ªÌ¹Keƒ]ªóªœ{Ÿ÷ÎÍđ–¤J +…)No##!"!&&*Z~DÛB@"

$"žÝYJl#2TLN6˜ªJæE

†qsZ#!²!%!²2TL)!²Itè;!÷

̏ZþJN6F•¥I;Dl#;@"H2CAP

žÝY¬„3UtèZÛ0OEJ†qsJY"ZÈT

;D!L:m˜¾Z©…;@"òÉKDÄ7œ=EH 2!¯/%-y†€ˆ‚]ˆrzt™E"!±Òk;

(3)

Mc]Oa%¤*%Çátª!ŸØ> ‘Çô

)&

7"6>™"!)EDTA&pH'"%'3v=9#³‡Ü~

47"

Ü~²6™!CAPכØKßx:„Ý4!„Ý.

/æÿ=<HE,=ÏÞ4!&om>cidNnÎ&

K¦É47"

%"Ò½Î&>Ѿ

Ò½Î&?pz>Ѿ)Kž87™!Ò½†§-E

@Ò½’ÖKž87"

"'efaTXjn#PRYn&HE'Ѿ

â)= ´ + e f a T X j n&Sigma-Aldrich*, St.

Louis, Mo, USA'-E@PRYnMkV$k&8š·

0œŽ!Ú¥'K4+9Ѿ47"

#'MWn#fmj$&Azan'Ѿ

ú+?!"")M\SkgnGv&þí{ƒ0ü!ë

Œ'=&¬‡Âã4!MbjnMkV$k=9#$4!

éMkV$k:ѾKä«47"6>™&)jn]

nUZ`n©Å3vß:$¬‡!ÅЙMbjnÊ#

RlnYG©¢Ÿv&þí{ƒ0ü!ëŒ'=9"

¬‡Âã47"

$'±Ì©çÆ©dQZdL]$[&TRAP'Ѿ

Ò½Î&?ÜcidNn™!Naphthol AS-MX phos- phate&Sigma-Aldrich*!St. Louis!Mo!USA'K ‰

®;49"M酺v:öyKž87"õ¾™!

!"!"N>NaOH3v=9öyKä«4!PBS=9Ð

¼™!efaTXjn:€Ñ¾47"

&"Ò½’Ö

AZANѾ=-+9pz=­5#°7>’ÖK

ž87"’Ö?ê'F#)'!¡F$!'>()=EGž87"

ì ’#Ë ?ANOVA: ž +!× µ ÷ ‚&Tukey- Kramer)'=EG1r£•åKž87"

"'ÁÈÒ½‘Ç5

ÁÈÒ½‘Ç5?CAPכ؄Ý.>û.Í=Ù 5HÁÈÒ½.Í>÷5K¨¶47"

#'ÁÈ ‘Ç5

ÁÈ ‘Ç5?ÁÈÒ½>Ó.Í=Ù5HÁÈ . Í&ÁÈÒ½ï>Ê0óÑ3I7ÿq'>÷5K¨¶

47"

“ }

""CAPMSC!ŸØ>SEM=EH†§

CAPכØû.?Õ|47¤*:"JI9-G!

MSC/CAPכØû.:Õ|49+H2;/†§

3I7&Ä#'"

#"i_aøzA>CAP!ŸØ,ñ

"'i_a>Mc]Oa,ñ™>ص>%{

¯—Їß>i_a=Ù¸!¯—:>ص=£

s?òCFI<.87"B7ðˆè=,ñÿq=w¹ öy?–FI<.87"

#'HEѾ=EHÒ½ƒè†§

&"'øz,ñ™%³

CAP‹›ÿ#A>Ò½>¿ñ/òCFI&Ä$%

a'!;0=BMP=-+9?CAPכØßxý

B:“ŸÒ½>¿ñ/ò3I7&Ä$%b'"

&#'øz,ñ™(³

(³/=-+9?Ù¸&Ä%%a';÷‚49BMP

&Ä%%b':EG“ŸÒ½>CAPכØïA>¿

ñ/ò3I7"BMP!FGF‡:?£?òCF I<.87"MSC&Ä%%c'=-+9!ßÀÿ=

?Û4<+D>>“ŸÒ½>¿ñ/à-=†§3I Ä""CAP!ŸØ¦Édm$^h$a

Ù¸?é|tª>uKù1H7C=!tªé|;

î2>»”:*H˜ØA,ñ47"

Ä#"CAP-MSC!ŸØ>SEMÔ&('!'

(4)

)&

2"

#&GHIpf9ADqeO|Uu

%!&qes

„K‰$a‹6;!ycS7ƒN/5BMPS!

FGFS*A<MSCS9*(5!CAPwZx€j‡

9>6V\qe,g/5(D:,M‚.E2">2

„K‰(a‹6;!BMPS!FGFS9*(5CAP wZxzh‡†R>6w:V\qe:tL!gF

‚?2%k%$a!b!c!d!e!f!g!h&"

%"&ioqeTn

„K‰"a‹6;!FGFS9*(5MSCS!

BMPS7ƒN/5ŒJ9ioqe:Tn,‚?BE 2">2BMPS7ycS7ƒN/2d\9*(5@

BMPS6ŒJ9V\qe:tLF‚?2%k&$a&"

$a‹9*(5ycS7:ƒNF[42d\!MSC

S*A<BMPS!FGFS9*(5ŒJ9V\qe :tLF‚?!~9BMPS9*(5W{9‚?BE 2%k&$b&"

.B9(a‹6;MSCS7BMPS!FGFS7:

Q9*(5@ŒJ^F‚?2"23/!BMPS!FGF

SQ6;ŒJ^;‚?BE8+42%k&$c&"

%#&io]Tn

„K‰"a‹6;BMPS9*(5]Tn:t L,vS7ƒN/5ŒJ9‚?BE2"%k'$a&"

„K‰$a‹9*(5@!"a‹}BMPS6 ]Tn:tL,ŒJ9‚?BE2,!1:v:S6

;ŒJ^;‚?BE8+42%k'$b&"

.B9„K‰(a‹9*(5@"a!$a}9 BMPS9*(5]Tn:tL,W{9‚?BE2"

/+/MSCS7FGFS:Q6;ŒJ^;‚?BE 8+42%k'$c&"

$&TRAPpf9ADqeO|P`

ycS6;$a‹*A<(a‹7@9TRAPŽm _ˆ;‚?BE8+42"BMPS:$a‹9;V\

qe…r9TRAPŽm_ˆ,‚?BE2"(a‹6

;ACwl:TRAPŽm_ˆF‚?2%k($a!b&"

FGFS9*(5@}9$a!(a7@9TRAP

Žm_ˆ,M‚.E2,!BMPS7ƒN0D7bl 6'42"

MSCS9*(5;$a‹6;TRAPŽm_ˆ;M k#"„K‰X $aHEpfs

a#V\qe:CAPwZx…r=:g,M‚.ED"

b#ycS7ƒN0D7CAPwZxjr‡>6w-:V\qe,tL!g/5(D:

,M‚.ED"

c#ycS7ƒN0D7!CAPwZx…r‡9Š8V\qe,g/5(D"

d#FGFS7}!…r‡9V\qe,tL!g/zh‡9Y+)qe@P`.ED"

(5)

R^YS\&•å&¶Êh›àÄB‘‚¶Ù

*(

× 3 N @ . : 9 /!)¢ ê A - * < C P 6 . A TRAPðµ•å/t×3N9"

 ˜

æ†}=C!ÎgK#&'AJ:<rÛ3N9CAPÃ

‹ÄQšï49"CAPCÎgK#%!#)'!ziK#''AJL CAP¶#§ƒª„I8Báòlv͵Ÿ-JD»

¬°õµBä/3N!XV`_%b]>4<ìï=

)O+>,KNM"CAPç։BaZ\BÄ£B ãlCŨ€ÒîA¾mŠQž492>.KH!

CAPB·ÄÕçÖA-1M·ÄEBfsµC¦@*

>³˜3NM"3KACAPAC•å-JD¶Êh›

BÇÄ>4<ñï5M9GA!’pB ˆ=C&!(|

‹óQì49ËÄQšï49"ËÄB|‹óC

&!(d©=ôÀ|‹Qì5M>¥ëK#*'/ž4<- L!ôÀ|‹Qì5M2>=•å-JD¶Êh›BÇ ÄA@LÔM>,!栈=C&!(|‹óQì5M CAPQšï49"

¶Êh›>4<BMP-#!FGF-#Qšï49"‘

íÓh›=)MBMP-#CMSCQ‘o•åEâl3

7M·òwµáŸ=)L*!$!!$"'!ALPwµ-JDPTH jϵQÉéA¿±4!TX[TUbWcB™·Hí Ó5M2>.K!MSCQ‘o•åAâl37!¸q lQíÓ5M>,KN<*M$#&$%'"FGF-#CÄÕB Ã0B»¬AÁ–4<*M"in vitroB†}A-*<

C!‘o•åB¾«¿±—ï$&'!MSCB‘o•åE Bâl$''/ä3N!~؜¡»¬”·=Bˆ/±

GKN<*M"

aZ\ÚßÝkACAPàÄBçÖQŽ*!ƒ

»¬-JDŒ»¬B‚¶BãlA;*<…Ð49"8 Bƒn!ƒ»¬B¾móA-*<CçÖ{y/Ê*

Ì!Ũ€>Üu4<MSC€=ìeA¾m4!3K ABMP€!FGF€A-*<CìeA¾m5Mƒn

>@:9"2BƒnJL!CAP-MSC-¶Êh›àÄ /·ÄÕ=B»¬”·AìñAÑ02>/ž“3N 9"Œ»¬B‚¶óA-*<C?BçÖ{yA-*<

H!BMP-#/Œ»¬‚¶¿±QìeA×GMƒn>

@:9"2NCº¤BËLBMP-#AJMMSCEB

—ïAJL¸ql/¿±3N99G=)M>³˜3N M"4.4@/K’pÂB¶Êh›€A-*<CMSC

²%"Ýkç։ HE¹­½ a$CAP|‹ßâAC%¢ê>ÒîAƒ»¬/×GKNM"

b$CAPËÄÕACôBƒ»¬Q×G!ȯßAF=ƒ»¬B®Ö/x˜3NM"

c$ËÄBȯßAH!è@ƒ»¬B®ÖQ×GM"

d$ȯßF=Æ4@*HBBÞ¼ßBƒ»¬/¾m/‡É=)M"

(6)

$#

V""ABCXR[

a#GKjk53JLYQ3Sd?e8<'!aTj53Sd4>,&/$<"

b#](3JLYQ3\D'Ee)=!hZiH/4W(fX)=-jk'Ee)=!M YQ0N>=<['Ee)=<"

c#_PI0gF+<0!CAP]K^hZj2:;](3JLYQ'Sd*.%<"

d#FGFI0cn!hZj2JLYQ'\D!Sd*.%<"

e#!Omcn!CAP]K^hZiH2.JLYQ?e8<"

f#!Om0g6aTj53JLYQ3Sd'U@/%<"

g#!Om0g6aTj53JLYQ3Sd'bl/$<"

h#aTj7/`*1%933hZj3JLYQ'\D*.%<"

(7)

IQMJO%u%†Wxœn<oc†˜

)) b9™\35€n!¢VrH—A:/65"CAPŒ kHFGF<937o•?Ÿ–35v;=¦j :d[0”DF5#''0!šY?<Ÿ–zh8=!FGF b;.-B¦j:lˆ‚c†=—ADF:/65"

CAP-MSC-†Wxœn<TNOšY•8<oc

†?<XaH^w3591G!CAP0MSC.C>

†Wx<¦j:LKSR$UP9:E19!@5

MSC0dnˆ‚.C>oˆ‚<s‡;.-7|¤:

¡]H[54190yq2F5"2D;BMP-"H‘

Z4E198lˆ‚<c†0Š„2FE19By2F 5"3/3žg`;.-7=‹<†Wx;.-7=

¦j:d[0”DF:/655A!pi‘Ze<~

u:f’0›¤8,E"

…'"

a#BMPb8¢V;‰Z37-E"

b#"{ “£!${ ;.-7BBMPb;.-7oc†

¥<‰ZH¢V;—AE"

c#({ 8B“£;BMPb8oc†¥=tBm-"

…&"

&n)$($b'

a#FGFb;¢VrH—AE"+p*!"!%

b#Ž}b9‹<b9<_;¢VrH—AE"

c#BMPb!FGFb;.-7ƒ‡ˆ‚0¢V;‰Z37 -E0!BMPb!FGFb8=¢VrH—A:-"

(8)

"!!

– 6

""Æ Ý r ª GCAP-MSCö ž Ö : á y 4 E 1 8 7!ͺ;¼ÇG+l:Ò¾4E18.®2F 5"

#"BMP-#GCAP-MSCöžÖ:áy4E187!

 “ÆG+l:Ò¾4E18.®2F5"

i¶;–z-C!CAPGSLb_%fY835 MSC,B=ÆÝrª;áy<ͺ¼Ç:+.7)E 18.®£2F5"

2sÏð'COI(

#6ù:‰36!~®4?/2sÏð·×<9*"

ù ˜

"(Langer R and Vacanti JP. Tissue Engineering.*-1/4-/!

"**$;#'!:*#!&*#'.

#(Kawaguchi H, Hirachi A, Hasegawa N, Iwata T, Hama- guchi H, Shiba H, Takata T, Kato Y and Kurihara H.

Enhancement of periodontal tissue regeneration by transplantation of bone marrow mesenchymal stem cells.' (/715.54952!#!!%;(&:"#)"&"#)(.

$(Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and Marshak DR. Multilineage potential of adult human mesenchymal stem cells.*-1/4-/!"***;

#)%:"%$&"%(.

%(Nauta AJ and Fibbe WE. Immunomodulatory proper- ties of mesenchymal stromal cells."255.!#!!(;""!:

$%**&$&!'.

&(Sato K, Ozaki K, Oh I, Meguro A, Hatanaka K, Nagai T, Muroi K and Ozawa K. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells."255.!#!!(;"!*:##)&#$%.

'(Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringdén O. HLA expression and immunologic proper-

ties of differentiated and undifferentiated mesenchy- mal stem cells.%<6 &/3,952!#!!$;$":)*!&)*'. ((Fromigué O, Marie PJ and Lomri A. Bone morphoge-

netic protein-#and transforming growth factor-beta

#interact to modulate human bone marrow stromal cell proliferation and differentiation. ' #/22 "15-0/3!

"**);'):%""&%#'.

)(Kobayashi M, Takiguchi T, Suzuki R, Yamaguchi A, Deguchi K, Shionome M, Miyazawa Y, Nishihata T, Nagumo M and Hasegawa K. Recombinant human bone morphogenetic protein-#stimulates osteoblastic differentiation in cells isolated from human periodontal ligament.' $/49 )/8!"***;():"'#%&"'$$.

*(Kadowaki A, Tsukazaki T, Hirata K, Shibata Y, Okubo Y, Bessho K, Komori T, Yoshida N and Yamaguchi A.

Isolation and characterization of a mesenchymal cell line that differentiates into osteoblasts in response to BMP-#from calvariae of GFP transgenic mice."54/!

#!!%;$%:**$&"!!$.

"!(‘#²q"o⪭4#Í@…+HW\JIfS^M

U%:BDBMP#oâªGçì35ˆ/”¥ÿm¸

:BE ¤Ç"§“p‚"#!!%$#)#("&(("

""(jæ"!yæ8!ý(!è"¬°­4>;Bone mor- phogenetic protein'BMP(;u.:‰4E™&e Ph]ZhXBMPïžPd%Oh$:BE “Æ;

‡¦&"묰«""**%$$'#&'&''"

"#(Èԝ¨!³ãåܽ!Ê5}›"rhBMP-#:BE

¬°Íº¤Ç8 Å*Û1Äþ;݋ßòx"묰

«"#!!#$%%#$('&$)'"

"$(yæ´¿!Ž­-©!ÂÙü!Ê5}›""ûÅ •

Ó:,0E¬¡µ{¯ñ'>;BMP-#äõ:BE¬

°Íº¤Çœz"묰«"#!!($%*##*'&$!%"

"%(~,¨!±éÚ¢!ØÞ"!v#à­"ê  øw;

RNZehNaK[T`&FGFRNZf;)ƒ&"

#544/-91;/ +188:/!"**(;#*:#"*&##'.

"&(Ozono S, Fujita T, Matsuo M, Todoki K, Ohtomo T, Negishi H and Kawase T. Co-treatment with basic fi- broblast growth factor and"(beta-estradiol in the presence of dexamethasone accelerates bone forma- tion by rat bone marrow stromal cell culture. ' '64 (758905.549 *5-!#!!);&#:$''&$(%.

"'(ú%Œ7!ÉŸô"FGF-#:BE€Îߗ†¼Ç

ĚaK[T`"&†‚"#!!%$%%#"&"&"&'"

"((ú%Œ7"—†¼Çrª#bFGF/FGF-#tŠÅÌn

|¥ÿѹrª"&†‚"#!!'$%'##*(&$!$"

")(Goto H, Matsuyama T, Miyamoto M, Yonamine Y and Izumi Y. Platelet-rich plasma/osteoblasts complex in- duces bone formation via osteoblastic differentiation following subcutaneous transplantation.' (/715.549,2 )/8!#!!';%":%&&&%'#.

"*(ÊÃÚî"¬°Íº¤ÇGÒ4Ç3„Å÷¯8¥ÿ4

þ:‰4EXdhSg%RcZfeQ%V"묰

À)"TRAPË»Ð

a#–žÍºñÎó’:TRAP0Å¥ÿ.í7/E"

b#¼Çͺ°k:ÕÁ;TRAP0Å¥ÿGíAE"

(9)

<JD=F&‰Ø&®ÀU‘Ô‡¶4ˆv®Ë

"!"

“"#!"!%&#$$&"$"

#!(oÒ¤‘!PsİÏ!}±s!íǹá!Ä¿84 :!²Ä¯"H=GO?A<JD=F×€4Àk x_£é3/*0"""޵”ä+95޵”4¥

z"ʔ˜“!"**(%$*$$'"&$'("

#"(~ÚTÍ!žèÁ‘!žÕ¯Û!t’e|!ÖSϊ

‘!¨S†"MEFÎY64H=GO?A<JD=F )ˆ}­‰ØH=KNEG¶R¦39;Qœ­ˆv

®"ʔ˜“""**(%$*$&!$&&"#"

##(~ÚTÍ!t’e|!„[TŸ!Þºæ!žèT…!

¬}§T!¨S†"b-FGF,b–¼¶)ˆ}­‰Ø H=KNEG¶4Qœ­ˆv®3+97.^"ʔ

˜“"#!!"%%$$&#&'%"

#$(Metsger DS, Drinskell TD and Paulstrud JR. Trical- cium phosphase ceramics, a resorbable bone implant, review and current status.) "6 %07< ";;8/!"*)#;"!&:

"!$&&"!$).

#%(ÆSÙ"½gß<JD=FI=>CMLE@B"Ê

”ã‚“"#!"%%$$$'&&(""

#&(ÆSÙ!ƒÄlW!´å¯É!•¡±T!€Çæ·!

m«™Ñ!©ìÙ"½gß<JD=F4¢y"”]

‹ç#ia""**&%"%$$"$&$#!"

#'(hVd!š»› !ÆSÙ!©ìÙ!hŒƒá"ˆ

׋2-04¢y½gß<JD=F4Ìâ‰Ø1 4ÐZ"j”c“"#!!"%#)$*!&"!""

#((¡\ܗ"½<JD=Fwˆ×‹"ÓX”¸“"

#!!(%$$$""*&"$""

#)(Doi Y, Koda T, Wakamatsu N, Goto T, Kamemizu H, Moriwaki Y, Adachi M and Suwa Y. Influence of car- bonate on sintering of apatite. ) %07< ,0;!"**$;(#:

"#(*&"#)%.

#*(žÝTê!ªÄën!fYq!uà³!t‘¾"

Hydroxyapatite Ceramics4rÅ2ˆÃÈË3/*0 4{p"Êv`“""**$%"$$&'"&&(""

$!(Rickard DJ, Sulivan TA, Shenker BJ, Leboy PS and Kazhdan I. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dex- amethasone and BMP-#.%0> #485!"**%;"'":#")&##).

$"(Kim IS, Song YM, Cho TH, Park YD, Lee KB, Noh I, Weber F and Hwang SJ. In vitro response of primary human bone marrow stromal cells to recombinant hu- man bone morphogenetic protein-#in the early and late stages of osteoblast differentiation. %0>0589 ':8?<3 %4110:!#!!);&!:&&$&&'%.

$#(Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T and Yoshiki S. Recom- binant human bone morphogenetic protein-#stimu- lates osteoblastic maturation and inhibits myogenic differentiation in vitro.) $055 #485!"**";""$:'()&')".

$$(Cowan CM, Aghaloo T, Chou YF, Walder B, Zhang X, Soo C, Ting K and Wu B. Micro CT evaluation of three-dimensional mineralization in response to BMP-

#doses in vitro and in critical sized rat calvarial de- fects.-4;;=0 &72!#!!(;"$:&!"&&"#.

$%(Hiraki Y, Inoue H, Shigeno C, Sanma Y, Bentz H, Rosen DM, Asada A and Suzuki F. Bone morphogenetic pro- teins'BMP-#and BMP-$(promote growth and expres- sion of the differentiated phenotype of rabbit chondro- cytes and osteoblastic MC$T$-E"cells in vitro. )

#870 *470: ,0;!"**";':"$($&"$)&.

$&(Thomson BM, Bennett J, Dean V, Triffitt J, Meikle MC and Loveridge N. Preliminary characterization of por- cine bone marrow stromal cells: skeletogenic potential, colony-forming activity, and response to dexametha- sone, transforming growth factor beta, and basic fibro- blast growth factor.) #870 *470: ,0;!"**$;):""($&

"")$.

$'(Pitaru S, Kotev ES, Noff D, Kaffuler S and Savion N. Ef- fect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells:

enhanced development of mineralized bone-like tissue in culture.) #870 *470: ,0;!"**$;):*"*&*#*.

$((K Keiichi, K Mitsunobu, S Masafumi, D Yutaka and S Toshiaki. Induction of new bone by basic FGF-loaded porous carbonate apatite implants in femur defects in rats.$547 +:.5 (695.7 ,0;!#!!*;#!:&'!&&'&.

参照

関連したドキュメント